Picture of Anebulo Pharmaceuticals logo

ANEB — Anebulo Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Anebulo Pharmaceuticals Reports Q2 Loss Of $0.15 Per Share

Feb 10 (Reuters) - Anebulo Pharmaceuticals Inc  ANEB.O :
    * ANEBULO PHARMACEUTICALS REPORTS SECOND QUARTER FISCAL YEAR
2023
FINANCIAL RESULTS AND RECENT UPDATES
    * NET LOSS IN Q2 OF FISCAL 2023 WAS $0.15 PER SHARE
    * Q2 EARNINGS PER SHARE VIEW $-0.11 -- REFINITIV IBES DATA
    * CASH WAS $16.4 MILLION AS OF DECEMBER 31, 2022

Source text for Eikon:  ID:nBw9YQ8Xfa 
Further company coverage:  ANEB.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Anebulo Pharmaceuticals

See all news